International Cancer Imaging Society

Our Journal - Cancer Imaging

Our Journal 1

Our Journal 1

Cancer Imaging is the official journal of ICIS, an open access, peer-reviewed journal published by BioMed Central. Original articles, as well as reviews and editorials written by international imaging experts with a subspecialty focus on oncology, are published regularly online;  sign up for alerts to keep up-to-date with the latest articles.  Alongside the 2013 impact factor of 1.29, Cancer Imaging is pleased to announce the 5-year impact factor of 1.76, enhanced by a very favourable Immediacy Index score.  

The journal encompasses CT, MRI, ultrasound, single photon and positron emission tomography, including multimodality imaging in all kinds of malignant tumours, plus new developments, techniques and innovations.

All articles published in Cancer Imaging are included in PubMed, the most widely used biomedical bibliographic database service, as well as Embase, EmCare, Google Scholar, MEDLINE, Science Citation Index and Scopus. The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature.

ICIS Members receive 15% discount on article-processing fees.

Submit your next manuscript to Cancer Imaging and take full advantage of the following:

Our Journal 4

Members Area

Subscribe to our mailing list

* indicates required
Email Format

Cancer / Oncology News From Medical News Today

GW Cancer Institute publishes core competencies for oncology patient navigators

Published: Sat, 18 Apr 2015 07:00:00 GMT

The George Washington University (GW) Cancer Institute has finalized 45 core competency statements for oncology patient navigators, who have become critical members of the health care team.

Smokers underestimate risks of a few cigarettes: Survey shows that many live in 'denial' of the real risks

Published: Fri, 17 Apr 2015 13:00:00 GMT

Many people still dangerously underestimate the health risks associated with smoking even a few cigarettes a day, despite decades of public health campaigning, French researchers have reported at...

Genetic variability may help predict tumor aggressiveness and treatment success

Published: Fri, 17 Apr 2015 10:00:00 GMT

A new method that measured genetic variability in tumor cells from patients with head and neck cancer found high scores correlated with lower patient survival.

New liver cancer treatment approved for use in Europe

Published: Fri, 17 Apr 2015 09:00:00 GMT

A new treatment for liver cancer developed by the University Medical Center (UMC) Utrecht has received the European CE mark for quality and safety.

Early use of palliative care in cancer improves patients' lives, outcomes for caregivers

Published: Fri, 17 Apr 2015 08:00:00 GMT

A new randomized clinical trial with Dartmouth investigators Kathleen Lyons, ScD, Tor Tosteson, ScD, Zhigang Li, PhD, and collaborators has noted significant improvement in several measures among...

Anti-fungal drug shows promise as potential new cancer treatment

Published: Fri, 17 Apr 2015 08:00:00 GMT

A common anti-fungal treatment has joined the ranks of drugs that may be suitable for use in treating cancer, according to research from the Repurposing Drugs in Oncology (ReDO) project published...

Tumor-only genetic sequencing may misguide cancer treatment in nearly half of all patients

Published: Fri, 17 Apr 2015 08:00:00 GMT

A study by Johns Hopkins scientists strongly suggests that sequencing tumor genomes for clues to genetic changes might misdirect treatment in nearly half of all patients unless it is compared first...

Racial disparity in cancer mortality is narrowing, suggests new study

Published: Fri, 17 Apr 2015 08:00:00 GMT

Cancer mortality remains significantly elevated among African Americans. Between 2000 and 2010, overall mortality from cancer decreased faster among African American women and men than among...

PharmaMar to present data on anticancer candidates PM1183 and plitidepsin at the AACR 2015

Published: Fri, 17 Apr 2015 07:00:00 GMT

American Association for Cancer Research Annual Meeting April 18-22, 2015 Combination of the anticancer drug PM1183 with PARP inhibitors and doxorubicin results in a synergistic effect...

African-American men at greater risk of prostate cancer, study finds

Published: Fri, 17 Apr 2015 07:00:00 GMT

Compared with non-Hispanic white men, obesity presented a higher prostate cancer risk and may be 'uniquely harmful' to African-American men, a new study finds.


27 February 2015

Registration opens for London 2015

Registration opens for London 2015

Prof. And ...
» Read more » Other news items